Olga D. Razinskaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Olga D. Razinskaya has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Elena A. Kovrazhkina
Federal Center of Brain Research and Neurotechnologies
2 shared publications - Johnathan Cooper-Knock
University of Sheffield
2 shared publications - Natalia Ninkina
School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK
2 shared publications - Vladimir L. Buchman
School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK
2 shared publications Abramenkova N.N. Abramenkova
1 shared publication- Adrian Higginbottom
Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK
1 shared publication
Latest Publications
- 25 July 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (7) , 102-107
Myasthenic syndrome in a patient with end-stage amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) and myasthenia gravis are diseases with similar clinical features but different prognosis and approach to treatment. It is possible as an extremely rare combination of these diseases, as well as myasthenia gravis with signs of ALS (MuSK-positive), as well as ALS, accompanied by myasthenic syndrome. Latter option is the most common. Myasthenic syndrome accompanying the ALS characterized by pathological muscle fatigue signs, symptoms variability during the day, partial sensitivity to neostigmine, M-wave decrements detection during electromyographyc study. We present a case of a patient with terminal ALS and myasthenic syndrome. The main pathogenesis theories of this condition and the differential diagnosis of ALS and myasthenia gravis are discussed.
- 25 July 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (7) , 102-107
Myasthenic syndrome in a patient with end-stage amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) and myasthenia gravis are diseases with similar clinical features but different prognosis and approach to treatment. It is possible as an extremely rare combination of these diseases, as well as myasthenia gravis with signs of ALS (MuSK-positive), as well as ALS, accompanied by myasthenic syndrome. Latter option is the most common. Myasthenic syndrome accompanying the ALS characterized by pathological muscle fatigue signs, symptoms variability during the day, partial sensitivity to neostigmine, M-wave decrements detection during electromyographyc study. We present a case of a patient with terminal ALS and myasthenic syndrome. The main pathogenesis theories of this condition and the differential diagnosis of ALS and myasthenia gravis are discussed.
- 12 December 2022
- Published by Bionika Media in Therapy
- Vol. 9_2022
Arterial hypertension and posterior reversible encephalopathy syndrome
- 12 December 2022
- Published by Bionika Media in Therapy
- Vol. 9_2022
Arterial hypertension and posterior reversible encephalopathy syndrome
- Open Access
- 1 January 2017
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 117 (8) , 4-10
Clinical polymorphism of amyotrophic lateral sclerosis
Medical article медицинская статья
- 1 January 2017
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 117 (8) , 4-10
Open AccessClinical polymorphism of amyotrophic lateral sclerosis
Medical article медицинская статья
- 1 October 2015
- Published by Elsevier in Neurobiology of Aging
- Vol. 36 (10) , 2908.e5-2908.e9
C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population
- 1 October 2015
- Published by Elsevier in Neurobiology of Aging
- Vol. 36 (10) , 2908.e5-2908.e9
C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population
- Open Access
- 1 January 2013
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 8 (1) , 12
Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation
Sizing of GGGGCC hexanucleotide repeat expansions within the C9ORF72 locus, which account for approximately 10% of all amyotrophic lateral sclerosis (ALS) cases, is urgently required to answer fundamental questions about mechanisms of pathogenesis in this important genetic variant. Currently employed PCR protocols are limited to discrimination between the presence and absence of a modified allele with more than 30 copies of the repeat, while Southern hybridisation-based methods are confounded by the somatic heterogeneity commonly present in blood samples, which might cause false-negative or ambiguous results.
- 1 January 2013
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 8 (1) , 12
Open AccessSimultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation
Sizing of GGGGCC hexanucleotide repeat expansions within the C9ORF72 locus, which account for approximately 10% of all amyotrophic lateral sclerosis (ALS) cases, is urgently required to answer fundamental questions about mechanisms of pathogenesis in this important genetic variant. Currently employed PCR protocols are limited to discrimination between the presence and absence of a modified allele with more than 30 copies of the repeat, while Southern hybridisation-based methods are confounded by the somatic heterogeneity commonly present in blood samples, which might cause false-negative or ambiguous results.